Darvon & Darvocet Lawsuit Claims Settlements Lawyer
The lawyers and attorneys at our law firm are currently investigating claims involving the use of Darvon & Darvocet and heart attack victims or other side effects. There are potential Darvon or Darvocet class action lawsuits starting and compensation from a settlement may occur.
If you or a loved one has taken either Darvon or Darvocet and experienced any bad side effects or other situations such as a heart related death, congestive heart failure or a cardiac death please contact the defective drug lawyers and attorneys at our firm today.
Some Darvon Darvocet users have asked:
- Do I have a Darvon Darvocet case or claim?
- What are the settlements for Darvon Darvocet lawsuits?
- Can I sue for my Darvon Darvocet use?
- What are the cash amounts for a Darvon Darvocet lawsuit?
- Are there time limits for a Darvon Darvocet case to be filed?
The FDA has finally at last banned Darvon, Darvocet, and other brand/generic drugs containing propoxyphene -- a painkiller that has been around since the 1950s.
In a new study just put out shows proof of heart side effects in healthy people taking normal doses of the drug triggered the Food and Drug Administration to take immediate actions.
There is an estimated 10 million people currently taking Darvocet and other propoxyphene painkiller drugs. The medical community has stated that users of Darvon or Darvocet should NOT immediately stop taking the drugs, as there is danger of severe withdrawal symptoms.
FDA on the Darvon & Darvocet Ban:
"Don't delay," warns Gerald Dal Pan, MD, MHS, director of the FDA's office of surveillance and epidemiology. The FDA action comes nearly six years after the drug was banned in the U.K., and nearly a year and a half after the European drug agency banned it.
The public interest group Public Citizen petitioned the FDA to ban the drug in 1978 and again in 2006. The latter petition caused the FDA to take the matter to an expert advisory committee, which in July 2009 voted 14-12 to ban the drug.
The FDA asked Darvon/Darvocet maker Xanodyne Pharmaceuticals Inc. to conduct studies of the drug's effects on the heart. The results of those studies led to the FDA ban.
John Jenkins, MD, director of the FDA's office of new drugs at the Center for Drug Evaluation and Research, mentioned at a news conference. "The drug puts patients at risk of abnormal or even fatal heart rhythm abnormalities, combined with prior safety data, this altered our risk assessment."
Jenkins says although it's impossible to know exactly how many deaths are linked to propoxyphene, an FDA study shows that more deaths are linked to the drug than to either of two alternative opioid painkillers, tramadol and hydrocodone.Dal Pan says that people who have taken Darvocet, Darvon, or other propoxyphene drugs for a long time are not at increased risk of heart problems."Long-term users should not worry: The heart effects are not cumulative," he says. "Once people stop using propoxyphene, the side effects should go away."More information about the propoxyphene ban is available on the FDA web site: http://www.fda.gov
****From the FDA on 11/19/2010***
ISSUE: FDA notified healthcare professionals that Xanodyne Pharmaceuticals has agreed to withdraw propoxyphene, an opioid pain reliever used to treat mild to moderate pain, from the U.S. market at the request of the FDA, due to new data showing that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. FDA concluded that the safety risks of propoxyphene outweigh its benefits for pain relief at recommended doses. FDA requested that the generic manufacturers of propoxyphene-containing products remove their products as well. BACKGROUND: FDA’s recommendation is based on all available data including data from a new study that evaluated the effects that increasing doses of propoxyphene have on the heart (see Data Summary in Drug Safety Communication). The results of the new study showed that when propoxyphene was taken at therapeutic doses, there were significant changes to the electrical activity of the heart: prolonged PR interval, widened QRS complex and prolonged QT interval. These changes can increase the risk for serious abnormal heart rhythms. ***END OF Darvon & Darvocet Ban***